Infliximab dose intensification by shortening infusion intervals

Inflamm Bowel Dis. 2008 Mar;14(3):432-4. doi: 10.1002/ibd.20314.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / pharmacokinetics
  • C-Reactive Protein / metabolism
  • Crohn Disease / drug therapy*
  • Crohn Disease / metabolism
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Gastrointestinal Agents / administration & dosage*
  • Gastrointestinal Agents / pharmacokinetics
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Middle Aged
  • Retrospective Studies
  • Severity of Illness Index
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • C-Reactive Protein
  • Infliximab